Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Potential living donor disqualification due to immunological factors

K Michalska, D Lewandowska, J Gozdowska, A Jałbrzykowska, I Sobierajska, M Durlik, M Nowaczyk

Ann Transplant 2009; 14(1): 69-69 :: ID: 880454

Abstract

Background: The objective of the study was to analyze retrospectively immunological factors as the reason for potential living kidney donor disqualification.
Material/Methods: Between 1995-2008, 340 individuals who volunteered to
donate kidney to a related recipient were evaluated at our centre. In potential donors, CDC tests with a potential recipient was performed. In cases, in which the recipient was awaiting a consecutive transplantation and the result of his cross-match with a potential donor was negative, HLA antigen expression was examined in the donor to exclude any HLA incompatibilities with the potential donor.
Results: Of 340 living kidney donor candidates, 206 individuals (61.5%) were
disqualified. Of these, 31 individuals (27%) were disqualified due to immunological reasons. In 23 individuals, the reason for disqualification was positive or doubtfully false result of the CDC test with the recipient. 3 individuals were disqualified in spite of the negative result of the cross-match due to the repetition of incompatibility, that is due to having the same HLA antigens that were found in the previous donor and were not present in the recipient. In 6 cases, the reason for disqualification was blood group incompatibility or a complete lack of HLA antigen compatibility (currently it is not an absolute contraindication).
Conclusions: Our results show that immunological factors constitute an important problem when selecting a living donor, especially for patients awaiting consecutive transplantations and immunized patients, even those in whom low titers of antibodies are found. In some cases, an advanced clinical examination of the donor should be preceded by an extended panel of immunological tests.

Keywords: Living Donor

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358